Dr. Julian A. Sanchez, MD

Dr. Sanchez practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Sanchez's NPI, 1821222480, was assigned on May 12, 2009. Dr. Sanchez graduated from Tufts University School Of Medicine in 2003. Dr. Sanchez holds Florida license ME117577.

Dr. Sanchez's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Sanchez's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Sanchez is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Sanchez to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanchez practices, 3 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Sanchez's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Sanchez is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Sanchez's licenses on file in 3 states: Florida, California and Ohio.

Dmand AI lists colonoscopy and colon removal among the conditions Dr. Sanchez treats.

CMS data shows 58 Medicare services from Dr. Sanchez across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $3,638 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Sanchez in 2024. The largest group is 65 to 74, with 47 patients. 72% of them have cancer, and 70% have high cholesterol. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sanchez's median patient age at 62, with 50% women.

In 2024, Dr. Sanchez wrote 75 Medicare Part D claims for 45 patients. 93% of them were for generic drugs. CMS names the drug for 36 of them, across 3 drugs with 11 or more claims each, at $75 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sanchez for performance year 2024, reported as part of a group. Dr. Sanchez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanchez as offering telehealth. CMS counts 26 procedures of colonoscopy by Dr. Sanchez, more than 51% of the clinicians it reports for that procedure.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Sanchez, published from 2008 to 2023. 2020 was the busiest year, with 3. The most frequent topics are Rectal Neoplasms, Sexual and Gender Minorities and Adenocarcinoma. Dr. Sanchez has published most often in Dis Colon Rectum. Dr. Sanchez's most frequent co-authors are Sophie Dessureault, MD, PhD, Seth Ian Felder, MD and Iman Imanirad, MD.

Dmand AI links Dr. Sanchez to 1 clinical trial.

CMS Open Payments shows 28 general payments to Dr. Sanchez from 6 drug and device companies from 2016 to 2025. Education make up the largest share, 32% of the total. THD America, Inc. paid the most, $4,366. It also lists 1 research payment totaling $1,155 in 2017.

Dmand AI lists 2 awards for Dr. Sanchez, most recently Fellow in 2015.

Dr. Sanchez graduated from Tufts University School Of Medicine in 2003. Dr. Sanchez is a member of ACS.

Dr. Sanchez is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.